Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
126.99Price to Sales
VS
Market
Sector
Industry
History
$ 35.65Close
$ 14.86 - $ 39.55 52-Week Range
Ticker Information
Ticker
DNTHCompany Name
DIANTHUS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDIANTHUS THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
DNTH - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 616.41M | 126.99 | $ 4.85M |
| 3/31/2025 | $ 645.77M | 98.98 | $ 6.52M |
| 12/31/2024 | $ 751.09M | 120.46 | $ 6.24M |
| 9/30/2024 | $ 884.95M | 164.92 | $ 5.37M |
| 6/30/2024 | $ 784.93M | 190.61 | $ 4.12M |
| 3/31/2024 | $ 731.68M | 324.47 | $ 2.25M |
| 12/31/2023 | $ 819.95M | 290.14 | $ 2.83M |
| 9/30/2023 | $ 169.07M | 182.98 | $ 924K |
| 6/30/2023 | $ 50.35M | 0 | $ 0 |
| 3/31/2023 | $ 42.45M | 0 | $ 0 |
Key Performance Insights, Last 5 Years
- DIANTHUS THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, DIANTHUS THERAPEUTICS INC's average P/S has been 187.44.
- The median P/S for DIANTHUS THERAPEUTICS INC during this period was 173.95
- DIANTHUS THERAPEUTICS INC reached its highest P/S over the past 5 years at 324.47.
- The lowest P/S recorded by DIANTHUS THERAPEUTICS INC in the same timeframe 98.98
DIANTHUS THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for DIANTHUS THERAPEUTICS INC is calculated as follows: Market Cap [ $ 318.81M ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] DNTH - Price to Sales, Last 5 years
98.98
Minimum
Mar 31, 2025
324.47
Maximum
Mar 31, 2024
187.44
Average
173.95
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |